Anti-Psychotic Meds Offer Hope Against Brain Cancer

FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma, new research indicates. "The anti-glioblastoma effects of these drugs are completely unexpected and were only uncovered because we carried out an unbiased genetic screen," said the lead author.